Follow Us TR

News Details

Theratechnologies to Develop Tesamorelin for the Treatment of NASH in the General Population

About Theratechnologies Inc.
  • NASDAQ: $THTX
  • Notified: $2.45
  • 07:30 EDT

Price Chart